Junwei Han
Orcid: 0000-0002-3276-0819Affiliations:
- Harbin Medical University, College of Bioinformatics Science and Technology, China
According to our database1,
Junwei Han
authored at least 12 papers
between 2013 and 2025.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on scopus.com
-
on orcid.org
On csauthors.net:
Bibliography
2025
J. Chem. Inf. Model., 2025
2024
IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data.
Briefings Bioinform., 2024
2023
DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19.
Comput. Biol. Medicine, June, 2023
iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network.
Briefings Bioinform., March, 2023
2022
DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network.
Bioinform., October, 2022
A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy.
Briefings Bioinform., 2022
2021
Nucleic Acids Res., 2021
SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs.
Bioinform., 2021
CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer.
Briefings Bioinform., 2021
2020
psSubpathway: a software package for flexible identification of phenotype-specific subpathways in cancer progression.
Bioinform., 2020
2014
The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure.
J. Biomed. Informatics, 2014
2013
Topologically inferring risk-active pathways toward precise cancer classification by directed random walk.
Bioinform., 2013